CT developer Xoran Technologies said it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the company's Tron mobile fluoroscopy/CT scanner.
Xoran's Tron mobile CT/fluoroscopy system.Tron is a mobile unit that can be installed in vans or wheeled to patients and can produce scans in under a minute, the company said. Xoran believes the system will "democratize" access to medical imaging.
Xoran also recently began work on the second phase of a mobile lung research project with the goal of confirming the safety and utility of a future thoracic point-of-care CT system in support of an FDA submission. The company said that these efforts in lung CT are supported by a recent grant award from the U.S. National Heart, Lung, and Blood Institute (NHLBI) through the National Institutes of Health (NIH).
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&dpr=2&fit=crop&h=167&q=70&w=250)
